Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

Revolutionary advancements in blood cancer treatment, from targeted therapy to gene editing, promise more effective and ...

The partnership will use Debiopharm's AbYlink conjugation tech in combination with Alkyon’s modular antibody platform.

MARTIGNY, Switzerland & LAUSANNE, Switzerland & SAN DIEGO, June 12, 2025--Debiopharm ( a privately-owned Swiss ...

Research program combining Debiopharm's AbYlink conjugation technology with Alkyon's modular antibody platform and novel targeting approaches is set to drive next-generation targeted radiopharmaceutic ...

We selected a streptavidin-coated 96-well plate to evaluate the antigen-binding capacity of the randomly and site-specifically biotinylated antibodies. This is a commercially available solid-phase ...

such as antigens or immunogens. That binding process depends on many factors. “One often overlooked parameter is the exact binding site of your antibody on the protein of interest, also known as ...

These are proteins that bind to specific antigens on target cells, such as bacteria. Monoclonal antibodies work similarly, binding only to specific antigens. This can help the body fight disease.

Each of these modified antibodies still maintained trastuzumab-specific binding to cells expressing the HER2 antigen, the target of trastuzumab ... that would allow release of the cargo at that site.